X4 Pharmaceuticals Company

X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Technology: Data-driven Technologies
Industry: Biotechnology, Clinical Trials, Health Care, Pharmaceutical, Therapeutics
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2014
Employees Number: 51-100
Funding Status: IPO
Investors Number: 12
Total Funding: 119499999
Estimated Revenue: Less than $1M
Last Funding Date: 2021
Last Funding Type: Post-IPO Equity

Visit Website
info@x4pharma.com
Register and Claim Ownership